A detailed history of Parkside Financial Bank & Trust transactions in Exact Sciences Corp stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 248 shares of EXAS stock, worth $14,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
248
Previous 77 222.08%
Holding current value
$14,411
Previous $3,000 433.33%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$42.43 - $70.83 $7,255 - $12,111
171 Added 222.08%
248 $16,000
Q2 2024

Aug 05, 2024

BUY
$41.33 - $74.26 $41 - $74
1 Added 1.32%
77 $3,000
Q1 2024

May 01, 2024

BUY
$56.27 - $73.77 $1,012 - $1,327
18 Added 31.03%
76 $5,000
Q4 2023

Feb 01, 2024

SELL
$59.06 - $75.72 $9,095 - $11,660
-154 Reduced 72.64%
58 $4,000
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $7,319 - $10,993
-111 Reduced 34.37%
212 $14,000
Q2 2023

Aug 15, 2023

SELL
$62.68 - $95.05 $10,843 - $16,443
-173 Reduced 34.88%
323 $30,000
Q1 2023

May 04, 2023

BUY
$47.19 - $70.77 $6,323 - $9,483
134 Added 37.02%
496 $33,000
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $10,197 - $17,858
336 Added 1292.31%
362 $17,000
Q3 2022

Nov 01, 2022

SELL
$31.97 - $49.37 $2,749 - $4,245
-86 Reduced 76.79%
26 $1,000
Q2 2022

Jul 13, 2022

BUY
$35.61 - $76.23 $3,596 - $7,699
101 Added 918.18%
112 $4,000
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $3,568 - $5,117
-62 Reduced 84.93%
11 $1,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $1,450 - $2,013
-20 Reduced 21.51%
73 $6,000
Q3 2021

Oct 29, 2021

SELL
$90.24 - $124.05 $14,348 - $19,723
-159 Reduced 63.1%
93 $9,000
Q2 2021

Aug 06, 2021

BUY
$93.66 - $139.27 $1,311 - $1,949
14 Added 5.88%
252 $31,000
Q1 2021

May 10, 2021

BUY
$116.57 - $155.01 $9,908 - $13,175
85 Added 55.56%
238 $32,000
Q4 2020

Feb 09, 2021

BUY
$99.61 - $142.12 $14,443 - $20,607
145 Added 1812.5%
153 $21,000
Q3 2020

Nov 06, 2020

SELL
$72.92 - $102.01 $8,896 - $12,445
-122 Reduced 93.85%
8 $1,000
Q2 2020

Aug 10, 2020

BUY
$55.75 - $92.75 $1,505 - $2,504
27 Added 26.21%
130 $11,000
Q1 2020

May 05, 2020

SELL
$37.9 - $104.44 $5,078 - $13,994
-134 Reduced 56.54%
103 $6,000
Q4 2019

Jan 30, 2020

BUY
$77.66 - $99.74 $3,494 - $4,488
45 Added 23.44%
237 $22,000
Q3 2019

Nov 05, 2019

BUY
$90.37 - $122.49 $903 - $1,224
10 Added 5.49%
192 $17,000
Q4 2018

Jan 31, 2019

BUY
$56.04 - $82.66 $2,297 - $3,389
41 Added 29.08%
182 $11,000
Q3 2018

Oct 12, 2018

BUY
$48.29 - $80.6 $6,808 - $11,364
141 New
141 $11,000
Q2 2018

Aug 03, 2018

SELL
$37.84 - $69.96 $4,654 - $8,605
-123 Closed
0 $0
Q1 2018

May 02, 2018

BUY
$39.82 - $57.53 $2,707 - $3,912
68 Added 123.64%
123 $5,000
Q4 2017

Feb 05, 2018

SELL
$46.49 - $60.51 $1,673 - $2,178
-36 Reduced 39.56%
55 $3,000
Q3 2017

Oct 27, 2017

BUY
$37.05 - $47.12 $3,371 - $4,287
91
91 $4,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.